Tara Iyengar - Concepedia

Author

Tara Iyengar

University of Pennsylvania

Also Known As

T. Iyengar, Tara D Iyengar, Tara D. Iyengar, Tara Iyengar

Publications

287

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania

About

Tara Iyengar is an author at University of Pennsylvania specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	260
2	Molecular Medicine	2	2	56
3	Obstetrics	2	2	88
4	Cell Biology	1	1	14
5	Immunology	1	1	42

Tara Iyengar

Publications

260

Citations

H-Index

Page 1

	Year	Citations
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m2 every 21 days in patients with cancer Glen J. Weiss, Ross C. Donehower, Tara Iyengar, Investigational New Drugs Kinase InhibitorMedicinePharmacologyCheckpoint 1Immune Checkpoint Inhibitor	2012	56
The Clinical Course of Deep Vein Thrombosis in Patients with Gynecologic Cancer Mark A. Morgan, Tara Iyengar, Beata E Napiorkowski, Gynecologic Oncology Clinical CoursePulmonary EmbolismThrombosisVenous ThrombosisMedicine	2002	52
A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma Daniel H. Sterman, Katherine L. Molnar-Kimber, Tara Iyengar, Cancer Gene Therapy Neuro-oncologyMalignant Pleural MesotheliomaPleural DiseaseMedicineSystemic Corticosteroid Administration	2000	46
Results from a phase I, dose-escalation study of PX-478, an orally available inhibitor of HIF-1α. Raoul Tibes, G. S. Falchook, Daniel D. Von Hoff, Journal of Clinical Oncology ImmunologyAvailable InhibitorPharmacotherapyAggressive Tumor GrowthTumor Biology	2010	42
Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter Tara Iyengar, Thomas J. Herzog American Journal of Hospice and Palliative Medicine® UrologySurgical OncologyAdvanced-stage Ovarian CancerMedicineGynecology	2002	36
Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors Tara Iyengar, Shu-Wing Ng, Ching C. Lau, Oncogene Ii IsoformsMedicinePathologyNf1 TypeSporadic Borderline	1999	14
First-in-human study with ARQ 621, a novel inhibitor of Eg5: Final results from the solid tumors cohort. L. C. Chen, Lee S. Rosen, Tara Iyengar, Journal of Clinical Oncology Final ResultsOncologyCell DivisionSolid TumorsMedicine	2011	14

Page 1